# The Relationship Between Trace Elements and Depression

**Authors:** Yuanjian Zhong, Yuxiang Nie, Yuanhui Mao, Yinting Liu, Tong Zou, Xiayun Liao, Lichun Zhao

PMC · DOI: 10.3390/nu18030484 · Nutrients · 2026-02-01

## TL;DR

This paper explores how trace elements like zinc and iron are linked to depression, suggesting they influence brain function and could aid in diagnosis and treatment.

## Contribution

The study integrates epidemiological, mechanistic, and network pharmacology evidence to reveal systemic roles of trace elements in depression.

## Key findings

- Dysregulation of trace elements like zinc, selenium, iron, and magnesium is closely linked to depression risk and symptom severity.
- Trace elements influence depression through mechanisms involving neurotransmission, oxidative stress, and neuroinflammation.
- Network pharmacology identifies hub targets like ALB, INS, and TP53, and key pathways such as calcium signaling and HIF-1.

## Abstract

Trace elements are widely involved in fundamental physiological processes, including enzymatic reactions, neurotransmitter metabolism, and redox homeostasis, and their balanced regulation plays an important role in maintaining normal brain development and neurological function. Depression is a complex psychiatric disorder characterized primarily by mood disturbances, with its onset and progression arising from long-term interactions among genetic susceptibility, neurobiological alterations, and environmental factors. A substantial body of epidemiological and clinical evidence indicates that dysregulation of trace elements—such as zinc, selenium, iron, and magnesium—is closely associated with the risk of depression and the severity of depressive symptoms. Mechanistic studies further demonstrate that trace elements influence depression-related pathophysiology through multi-target and multi-pathway mechanisms, including modulation of monoaminergic neurotransmission, neuroinflammation, oxidative stress, mitochondrial energy metabolism, and hypothalamic–pituitary–adrenal axis function. Network pharmacology analyses have additionally identified systemic hub targets, such as albumin (ALB), insulin (INS), and TP53, as well as key pathways including calcium signaling, neuroactive ligand–receptor interactions, and the HIF-1 signaling pathway. These findings suggest that trace elements may regulate depression-related pathological processes through coordinated network-level effects. Collectively, these integrative insights provide a theoretical basis for the application of trace elements in depression risk assessment, the development of precision intervention strategies, and future mechanistic investigations.

## Linked entities

- **Genes:** ALB (albumin) [NCBI Gene 213], INS (insulin) [NCBI Gene 3630], TP53 (tumor protein p53) [NCBI Gene 7157]
- **Chemicals:** zinc (PubChem CID 23994), selenium (PubChem CID 6326970), iron (PubChem CID 23925), magnesium (PubChem CID 5462224)
- **Diseases:** depression (MONDO:0002050)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** mood disturbances (MESH:D019964), Depression (MESH:D003866), psychiatric disorder (MESH:D001523), neuroinflammation (MESH:D000090862)
- **Chemicals:** selenium (MESH:D012643), iron (MESH:D007501), zinc (MESH:D015032), calcium (MESH:D002118), magnesium (MESH:D008274)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12899835/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12899835/full.md

## References

271 references — full list in the complete paper: https://tomesphere.com/paper/PMC12899835/full.md

---
Source: https://tomesphere.com/paper/PMC12899835